Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F9 | P00740 | 1/20 | 0.36 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.36 |
| ▸ | LIMK1 | P53667 | 1/20 | 0.34 |
| ▸ | MAP3K8 | P41279 | 2/20 | 0.33 |
| ▸ | SLC9A1 | P19634 | 1/20 | 0.33 |
| ▸ | GPR3 | P46089 | 1/20 | 0.32 |
| ▸ | PIM3 | Q86V86 | 1/20 | 0.31 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.31 |
| ▸ | CRHR1 | P34998 | 1/20 | 0.30 |
| ▸ | CA12 | O43570 | 1/20 | 0.30 |
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
| ▸ | CA9 | Q16790 | 1/20 | 0.30 |
| ▸ | BRDT | Q58F21 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24370037 | 0.96 | F9 (0.34) | F9ALOX5LIMK1MAP3K8SLC9A1 | |
| SCHEMBL24370277 | 0.94 | F9 (0.34) | F9ALOX5LIMK1MAP3K8SLC9A1 | |
| SCHEMBL22255320 | 0.94 | S1PR5 (0.36) | F9ALOX5LIMK1SLC9A1CRHR1 | |
| SCHEMBL24370073 | 0.94 | F9 (0.37) | F9ALOX5LIMK1SLC9A1GPR3 | |
| SCHEMBL22255451 | 0.93 | S1PR5 (0.35) | F9ALOX5LIMK1SLC9A1CRHR1 | |
| SCHEMBL23237922 | 0.93 | F9 (0.38) | F9ALOX5SLC9A1CA12CA1 | |
| SCHEMBL22255349 | 0.93 | F9 (0.34) | F9ALOX5LIMK1SLC9A1GPR3 | |
| SCHEMBL24370010 | 0.93 | F9 (0.36) | F9ALOX5LIMK1SLC9A1GPR3 | |
| SCHEMBL24999208 | 0.93 | F9 (0.33) | F9ALOX5SLC9A1GPR3PIM3 | |
| SCHEMBL24370051 | 0.92 | F9 (0.36) | F9ALOX5LIMK1SLC9A1GPR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220131079-A1 | LIGHT EMITTING DEVICE AND AMINE COMPOUND FOR THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2022-04-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220131079-A1 | LIGHT EMITTING DEVICE AND AMINE COMPOUND FOR THE SAME | MAOA, AOC1, ALDH1A2 | F9 2055/4885ALOX5 582/4885LIMK1 339/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.